Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | NMT1 | P30419 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | FABP7 | O15540 | 1/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PLAT | P00750 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27724950 | 0.91 | ALDH1A1 (0.54) | TSHRALDH1A1GAASMN1; SMN2NPC1 | |
| SCHEMBL606466 | 0.88 | TSHR (0.55) | TSHRALDH1A1GAASMN1; SMN2NPC1 | |
| Hydrochloric Acid SCHEMBL3494457 | 0.87 | TSHR (0.57) | TSHRALDH1A1GAASMN1; SMN2NPC1 | |
| SCHEMBL27724941 | 0.87 | ALDH1A1 (0.50) | TSHRALDH1A1GAASMN1; SMN2NPC1 | |
| SCHEMBL434313 | 0.85 | HTR2C (0.52) | TSHRALDH1A1GAASMN1; SMN2NPC1 | |
| Alcohol SCHEMBL27541427 | 0.83 | TSHR (0.53) | TSHRALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL28687641 | 0.83 | TSHR (0.53) | TSHRALDH1A1GAASMN1; SMN2NPC1 | |
| SCHEMBL22338484 | 0.82 | L3MBTL1 (0.47) | TSHRALDH1A1GAASMN1; SMN2NPC1 | |
| SCHEMBL7412066 | 0.81 | TSHR (0.48) | TSHRALDH1A1GAASMN1; SMN2NPC1 | |
| SCHEMBL8692031 | 0.80 | ALDH1A1 (0.53) | TSHRALDH1A1GAASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113976072-B | Preparation device and method of 4-formyl-N-CBZ piperidine | 武汉青风凯默生物医药科技有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-118076599-A | Dioxazines and their use in the treatment of GBA related diseases | 泽拉丹麦有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-113976072-B | Preparation device and method of 4-formyl-N-CBZ piperidine | 武汉青风凯默生物医药科技有限公司 | 2024-02-23 | — | — | CN | disclosed |
| EP-2956441-A1 | MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL | The Scripps Research Institute (US) | 2015-12-23 | — | — | EP | disclosed |
| WO-2014127350-A1 | MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL | THE SCRIPPS RESEARCH INSTITUTE (US) | 2014-08-21 | — | — | WO | disclosed |
| EP-1399160-A4 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | MERCK & CO INC (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-1399160-A2 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | Merck & Co., Inc. (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002100352-A2 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | MERCK & CO., INC. (US) | 2002-12-19 | — | — | WO | disclosed |